November 22, 2023
Positive Results from ReVeRA Phase 2 Study of Etripamil Nasal Spray in AFib-RVR Presented by Milestone Pharmaceuticals during AHA 2023
November 24, 2023 — During the American Heart Association Scientific Sessions 2023, held recently in Philadephia, PA,…
Read More
A groundbreaking advancement in the treatment of patients with uncontrolled hypertension (HTN) has been achieved with the recent U.S. Food & Drug Administration (FDA) approvals of two renal denervation (RDN) systems
November 22, 2023
Renal HeartSciences Announces Closing of License Agreements with the Icahn School of Medicine at Mount Sinai to Develop and Commercialize AI Cardiovascular Algorithms
November 22, 2023 — Heart Test Laboratories, Inc. d/b/a HeartSciences, an artificial intelligence (AI)-powered medical…
Read More
Medinbox Link and Medinbox Air deliver cutting-edge technologies to enhance digital education and remote proctoring and support for cath labs and interventional rooms globally
November 22, 2023
Medinbox Advances Company Mission to Improve Access to Medical Education and Remote Support Around the World with Debut of New Product Suites for Interventional Ecosystem at TCT
November 22, 2023 — Medinbox, a leading global provider of video integrated collaboration systems for interventional…
Read More
The first clinical trial to challenge the routine implantation of a defibrillator in myocardial infarction survivors with heart failure has enrolled its first patient.
November 22, 2023
Trial to Prevent Sudden Death After a Heart Attack Enrolls First Patient
November 22, 2023 — The first clinical trial to challenge the routine implantation of a defibrillator in myocardial…
Read More
November 21, 2023
BridgeBio Pharma Presents Additional Clinical Outcomes Data from the Phase 3 ATTRibute-CM Study of Acoramidis in Patients with Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
November 21, 2023 — BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company focused on genetic diseases…
Read More
New partnership paves the way for early diagnosis and intervention to improve cardiovascular outcomes and quality of life for patients
November 21, 2023
AccurKardia Delivers its ECG Interpretation Software Within the Lucem Health Reveal Family of Clinical AI Solutions
November 21, 2023 — AccurKardia, an ECG-led diagnostics software company, announced a multi-year agreement with Lucem…
Read More
AI-powered NeuroShield automatically quantifies brain volumes using MRI data – the first of its kind with the capability to provide ethnicity-specific reference ranges
November 21, 2023
Heuron Showcasing Neuro AI Solutions and Presenting Abstract on AI Solutions for Stroke at RSNA23
November 21, 2023 — Heuron, a medical AI (artificial intelligence) imaging software solution company, under the…
Read More
A cardiac follow-up is recommended for all children who have been treated for MIS-C
November 20, 2023
Investigators at Children’s Hospital Los Angeles Find Heart Complications in Many Children Treated for MIS-C
November 20, 2023 — In the U.S., nearly 10,000 children and adolescents have developed a condition called multisystem…
Read More
New data from the ARIES trial show for the first time that an aspirin-free regimen can improve outcomes for people living with the heart pump by reducing hospitalizations without increasing the risk of blood clots
November 20, 2023
Late-breaking Data Show an Aspirin-free Medication Regimen Benefits People with Abbott’s HeartMate 3 Heart Pump
November 20, 2023 — Abbott announced new late-breaking data that show advanced heart failure patients living with its …
Read More
Team Bath Heart’s artificial heart wins top prize at international engineering & design contest
November 20, 2023
Heart of Gold: Bath Student Team Wins World Heart Hackathon Competition
November 20, 2023 — Student engineers from the University of Bath are on top of the world after winning an…
Read More
Approval is the culmination of ten years of clinical research and development of the Medtronic renal denervation technology
November 20, 2023
Medtronic Announces FDA Approval of Minimally Invasive Device to Treat Hypertension
November 20, 2023 — Medtronic plc, a global leader in healthcare technology, announced that the United States Food and…
Read More
A groundbreaking advancement in the treatment of patients with uncontrolled hypertension (HTN) has been achieved with the recent U.S. Food & Drug Administration (FDA) approvals of two renal denervation (RDN) systems
November 20, 2023
Renal Denervation Systems Receive FDA Approval, Revolutionizing Treatment for Uncontrolled Hypertension
November 20, 2023 — A groundbreaking advancement in the treatment of patients with uncontrolled hypertension (HTN) has…
Read More
Recent recommendations for remote monitoring of implantable devices may require healthcare organizations to rethink how they staff their operations
By Arnaud Rosier, MD, PhD
November 20, 2023
Expert Consensus on Remote Monitoring: Key Staffing Takeaways
This past spring, electrophysiology experts issued new recommendations for remote monitoring of cardiovascular…
Read More
Investigators in the Smidt Heart Institute found that electrocardiogram changes picked up over time could indicate increased risk
November 17, 2023
Cedars-Sinai Investigators Move Closer to Predicting Sudden Cardiac Arrest
November 17, 2023 — Sudden cardiac arrest remains a deadly and complex condition, but investigators in the Smidt Heart…
Read More
BioCardia announces that the Food and Drug Administration (FDA) has approved its proposed CardiAMP Heart Failure II study protocol
November 17, 2023
BioCardia Announces FDA Approval of CardiAMP Heart Failure II Protocol for Autologous Cell Therapy for Ischemic Heart Failure
November 17, 2023 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of…
Read More
Researchers from the University of Minnesota Medical School examining the cause of cardiomyopathy discovered one out of every six patients with coronary artery disease had non-ischemic or dual cardiomyopathy
November 17, 2023
University of Minnesota Medical School Researchers Investigate Cause of Cardiomyopathy in Coronary Artery Disease Using Cardiac MRI
November 17, 2023 — Researchers from the University of Minnesota Medical School examining the cause of cardiomyopathy…
Read More
The model automatically pinpoints the location of cardiac catheters in photoacoustic images, paving the way for safer cardiac procedures
November 16, 2023
Using Deep Learning to Process Raw Photoacoustic Channel Data and Guide Cardiac Interventions
November 16, 2023 — Cardiovascular diseases rank among the top causes of death across the world, and cardiac…
Read More
Findings will help scientists understand how microgravity impacts the ability of human heart cells to withstand the stresses of space travel
November 16, 2023
Mount Sinai Bioengineers Send Cardiac Muscle Samples Into Space to Study Heart Cell Biology in Microgravity
November 16, 2023 — Mount Sinai’s Cardiovascular Research Institute is sending bioengineered human heart muscle cells…
Read More
In the trial of more than 400 adults with heart failure in Israel, the app predicted the need for hospitalization about three weeks in advance of a heart failure event
November 16, 2023
AI-phone App Detected Worsening Heart Failure Based on Changes in Patients’ Voices
November 16, 2023 — A smartphone app using artificial intelligence technology to detect changes in the voice of a…
Read More
Innovative new treatment option for patients with uncontrolled hypertension now available in the United States
November 15, 2023
Recor Medical Announces U.S. Launch and First Commercial Cases of Paradise Ultrasound Renal Denervation Therapy
November 15, 2023 — Recor Medical, Inc. and its parent company, Otsuka Medical Devices Co., Ltd. announced the first…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now